Gut microbiome depletion aggravates glial-mediated Alzheimer’s disease pathology through inflammatory, metabolic, and proteostatic dysregulation
- 1Department of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
- 2UAB Nathan Shock Center, Birmingham, AL, USA
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by chronic neuroinflammation, metabolic dysfunction, and impaired proteostasis. Emerging evidence suggests that the gut microbiome influences brain function through the gut–brain axis; however, the mechanisms by which this communication affects AD pathology remain poorly understood. In this study, we used humanized Drosophila AD models expressing human AD-related transgenes in glial cells to investigate how glial AD pathology influences the gut microbiome and how microbiome depletion affects behavior and disease progression. Our findings revealed significant alterations in the abundance of several gut microbial taxa, including Lactobacillus, Acetobacter, Enterococcus, Enterobacter, Pseudomonas, Leuconostoc, Providencia, and Gluconobacter, suggesting a potential interaction between the gut microbiome and AD progression. To further define the role of the gut microbiome in AD progression, we treated Drosophila with antibiotics to achieve substantial microbiome depletion (SMD) and evaluated the resulting behavioral, physiological, and molecular changes. Compared with conventional controls, flies with SMD exhibited enhanced inflammatory signaling and cell death, impaired autophagy, lipid dysregulation, and increased accumulation of amyloid β-42 (aβ42) and phospho-tau (pTau), with the extent of these changes varying among the different humanized AD models. These molecular alterations further exacerbated sleepcircadian disruption, altered locomotor performance, and worsened learning and memory deficits. Furthermore, we demonstrated a link between enhanced neuroinflammation and the accumulation of aβ42, pTau, and amyloid precursor protein (APP) proteins. Collectively, our findings demonstrate that gut microbiome depletion aggravates glial-mediated AD pathology through the coordinated disruption of inflammatory, metabolic, and proteostatic pathways, ultimately leading to behavioral dysfunction. These results identify the gut microbiome as a critical regulator of glial homeostasis and provide new insights into its contribution to the progression of neurodegenerative disorders.
Related
- LPS-Induced Inflammatory Microenvironment Aggravates Urothelial Cell Damage and MAP Crystal Adhesion
- Immune checkpoint inhibitors and the inflammatory dysregulation: decoding cutaneous and gastrointestinal immune-related adverse events for the allergist and immunologist
- Phage-directed precision microbiome medicine: engineering pathobiont depletion, synbiotic succession, microbial-function editing, metabolite host signaling, neurophagomics, and durable ecological state control in gut dysbiosis associated diseases
- Inflammatory biomarkers and immune dysregulation in gestational diabetes mellitus: emerging mechanisms and therapeutic prospects
- Granzyme K associates with inflammatory immune programs and B-cell dysregulation in systemic lupus erythematosus
BibTeX
@article{madamanchi2026microbiome,
title = {{Gut microbiome depletion aggravates glial-mediated Alzheimer’s disease pathology through inflammatory, metabolic, and proteostatic dysregulation}},
author = {Kishore Madamanchi and Srinath Gurrala and John Watson and Girish Melkani},
journal = {Gut Microbes},
year = {2026},
month = nov,
doi = {10.1080/19490976.2026.2753247},
url = {https://doi.org/10.1080/19490976.2026.2753247},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Gut microbiome depletion aggravates glial-mediated Alzheimer’s disease pathology through inflammatory, metabolic, and proteostatic dysregulation
AU - Kishore Madamanchi
AU - Srinath Gurrala
AU - John Watson
AU - Girish Melkani
PY - 2026
DA - 2026/11/08
JO - Gut Microbes
DO - 10.1080/19490976.2026.2753247
UR - https://doi.org/10.1080/19490976.2026.2753247
AB - Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by chronic neuroinflammation, metabolic dysfunction, and impaired proteostasis. Emerging evidence suggests that the gut microbiome influences brain function through the gut–brain axis; however, the mechanisms by which this communication affects AD pathology remain poorly understood. In this study, we used humanized Drosophila AD models expressing human AD-related transgenes in glial cells to investigate how glial AD pathology influences the gut microbiome and how microbiome depletion affects behavior and disease progression. Our findings revealed significant alterations in the abundance of several gut microbial taxa, including Lactobacillus, Acetobacter, Enterococcus, Enterobacter, Pseudomonas, Leuconostoc, Providencia, and Gluconobacter, suggesting a potential interaction between the gut microbiome and AD progression. To further define the role of the gut microbiome in AD progression, we treated Drosophila with antibiotics to achieve substantial microbiome depletion (SMD) and evaluated the resulting behavioral, physiological, and molecular changes. Compared with conventional controls, flies with SMD exhibited enhanced inflammatory signaling and cell death, impaired autophagy, lipid dysregulation, and increased accumulation of amyloid β-42 (aβ42) and phospho-tau (pTau), with the extent of these changes varying among the different humanized AD models. These molecular alterations further exacerbated sleepcircadian disruption, altered locomotor performance, and worsened learning and memory deficits. Furthermore, we demonstrated a link between enhanced neuroinflammation and the accumulation of aβ42, pTau, and amyloid precursor protein (APP) proteins. Collectively, our findings demonstrate that gut microbiome depletion aggravates glial-mediated AD pathology through the coordinated disruption of inflammatory, metabolic, and proteostatic pathways, ultimately leading to behavioral dysfunction. These results identify the gut microbiome as a critical regulator of glial homeostasis and provide new insights into its contribution to the progression of neurodegenerative disorders.
SN - 1949-0976
SN - 1949-0984
ER -